鲍曼不动杆菌感染诊治的挑战与对策探讨
The Challenge and Countermeasure to the Diagnosis and Treatment of Acinetobacter baumannii Infection

作者: 石庆柳 :贵州医科大学,贵州 贵阳; 彭春红 , 叶贤伟 , 张湘燕 :贵州省人民医院呼吸与危重症医学科,贵州省呼吸疾病研究所,贵州 贵阳;

关键词: 鲍曼不动杆菌定植感染耐药性Acinetobacter baumannii Colonization Infection Resistance

摘要:
鲍曼不动杆菌获取耐药基因的能力及在院内范围的广泛传播越来越引起人们关注,尤其是在重症监护病房,泛耐药的鲍曼不动杆菌的分离率日渐增多。如何有效的区分鲍曼不动杆菌的定植还是感染,不但对患者预后有帮助,同时避免抗生素过度使用,降低鲍曼不动杆菌的抗生素选择压力同时避免严重耐药的产生有重要意义。

Abstract: Acinetobacter baumannii deserves close attention for the remarkable ability to upregulate or ac-quire resistance determinants. The genus is a very effective human colonizer in the hospital and can cause nosocomial spread, especially in intensive care unit. Therefore, it is important to distinguish between infection and colonization with A. baumannii, which can not only improve the prognosis of patients with infection but also decrease the risk of antibiotic resistance of patients with colonization.

文章引用: 石庆柳 , 彭春红 , 叶贤伟 , 张湘燕 (2016) 鲍曼不动杆菌感染诊治的挑战与对策探讨。 临床医学进展, 6, 68-74. doi: 10.12677/ACM.2016.61013

参考文献

[1] Marie, K. and Rolain, J.-M. (2012) Emergence of Resistance to Carbapenems in Acinetobacter baumannii in Europe: Clinical Impact and Therapeutic Options. International Journal of Antimicrobial Agents, 39, 105-114.
http://dx.doi.org/10.1016/j.ijantimicag.2011.10.004

[2] Giamarellou, H., Antoniadou, A. and Kanellakopoulou, K. (2008) Acinetobacter baumannii: A Universal Threat to Public Health? International Journal of Antimicrobial Agents, 32, 106-119.
http://dx.doi.org/10.1016/j.ijantimicag.2008.02.013

[3] Peleg, A.Y., Seifert, H. and Paterson, D.L. (2008) Aci-netobacter baumannii: Emergence of a Successful Pathogen. Clinical Microbiology Reviews, 21, 538-582.
http://dx.doi.org/10.1128/CMR.00058-07

[4] (2004) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004. American Journal of Infection Control, 32, 470-485.
http://dx.doi.org/10.1016/j.ajic.2004.10.001

[5] 刘又宁, 曹彬, 王辉, 等. 中国九城市成人医院获得性肺炎微生物学与临床特点调查[J]. 中华结核和呼吸杂志, 2012, 35(10): 739-746.

[6] 杨青, 俞云松, 孙自镛, 等. 2011年中国CHINET呼吸道病原菌分布和耐药性监测[J]. 中国感染与化疗杂志, 2013, 13(5): 357-364.

[7] 汪复, 朱德妹, 胡付品, 等. 2008年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志, 2009, 9(5): 321-329.

[8] 汪复, 朱德妹, 胡付品, 等. 2009年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志, 2010, 10(5): 325-334.

[9] 朱德妹, 汪复, 胡付品, 等. 2010年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志, 2011, 11(5): 321-329.

[10] 胡付品, 朱德妹, 汪复, 等. 2011年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志, 2012, 12(5): 321-329.

[11] 汪复, 朱德妹, 胡付品, 等. 2012年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志, 2013, 13(5): 321-330.

[12] 胡付品, 朱德妹, 汪复, 等. 2013年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志, 2014, 14(5): 365-374.

[13] 胡付品, 朱德妹, 汪复, 等. 2014年中国CHINET细菌耐药性监测[J]. 中国感染与化疗杂志, 2015, 15(5): 401-410.

[14] Lemos, E.V., et al. (2014) Carbapenem Resistance and Mortality in Patients with Acinetobacter baumannii Infection: Systematic Review and Meta-Analysis. Clinical Microbiology and Infection, 20, 416-423.
http://dx.doi.org/10.1111/1469-0691.12363

[15] 朱迎钢, 瞿介明. 医院感染治疗中的一个难以决策的问题: 定植还是感染? [J]. 中国呼吸与危重症杂志, 2011, 10(5): 421-423.

[16] Yu Victor, L. (2011) Guidelines for Hos-pital-Acquired Pneumonia and Health-Care-Associated Pneumonia: A Vulnerability, a Pitfall, and a Fatal Flaw. The Lancet Infectious Diseases, 11, 248-252.
http://dx.doi.org/10.1016/S1473-3099(11)70005-6

[17] Barati, M., Bashar, F.R., Shahrami, R., et al. (2010) So-luble Triggering Receptor Expressed on Myeloid Cells 1 and the Diagnosis of Sepsis. Journal of Critical Care, 25, e1-e6.
http://dx.doi.org/10.1016/j.jcrc.2009.10.004

[18] Batirel, A., Balkan, I., Karabay, O., et al. (2014) Comparison of Colistin-Carbapenem, Colistin-Sulbactam, and Colistin plus Other Antibacterial Agents for the Treatment of Extremely Drug-Resistant Acinetobacter baumannii Blood Stream Infections. European Journal of Clinical Microbiology & Infectious Diseases, 33, 1311-1322.
http://dx.doi.org/10.1007/s10096-014-2070-6

[19] Zalts, R., Neuberger, A., Hussein, K., et al. (2013) Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison between Intravenous Colistin and Intravenous Ampicillin- Sulbactam. American Journal of Therapeutics, 23, e78-e85.

[20] Oleksiuk, L.M., Nguyen, M.H., Press, E.G., et al. (2014) In Vitro Responses of Acinetobacter baumannii to Two- and Three-Drug Combinations Following Exposure to Colistin and Doripenem. Antimicrobial Agents and Chemotherapy, 58, 1195-1199.
http://dx.doi.org/10.1128/AAC.01779-13

[21] López-Cortés, L.E., Cisneros, J.M., Fernández-Cuenca, F., et al. (2014) Monotherapy versus Combination Therapy for Sepsis Due to Multidrug-Resistant Acinetobacter baumannii: Analysis of a Multicentre Prospective Cohort. Journal of Antimicrobial Chemotherapy, 69, 3167-3168.
http://dx.doi.org/10.1093/jac/dku327

[22] Giannouli, M., Di Popolo, A., Durante-Mangoni, E., et al. (2012) Molecular Epidemiology and Mechanisms of Rifampicin Resistance in Acinetobacter baumannii Isolates from Italy. International Journal of Antimicrobial Agents, 39, 58-63.
http://dx.doi.org/10.1016/j.ijantimicag.2011.09.016

[23] Hagihara, M., Housman, S.T., Nicolau, D.P., et al. (2014) In Vitro Pharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 58, 874-879.
http://dx.doi.org/10.1128/AAC.01624-13

[24] 佰义, 何礼贤, 胡必杰, 等. 中国鲍曼不动杆菌感染诊治与防控专家共识[J]. 中华医学杂志, 2012, 92(2): 76-85.

[25] Jung, J.Y., Park, M.S., Kim, S.E., et al. (2010) Risk Factors for Multi-Drug Resistant Acinetobacter baumannii Bacteremia in Patients with Colonization in the Intensive Care Unit. BMC Infectious Diseases, 10, 228.
http://dx.doi.org/10.1186/1471-2334-10-228

分享
Top